Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$20.10 USD
+0.07 (0.35%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $20.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
FLGT 20.10 +0.07(0.35%)
Will FLGT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for FLGT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FLGT
Privia Health (PRVA) Misses Q4 Earnings Estimates
Health Catalyst (HCAT) Q4 Earnings and Revenues Beat Estimates
FLGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates
Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength?
Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates
Other News for FLGT
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
What's Driving Twist Bioscience Corp's Surprising 44% Stock Rally?
Piper Sandler Sticks to Its Hold Rating for Fulgent Genetics (FLGT)
Fulgent Genetics price target lowered by $3 at Piper Sandler, here's why
Fulgent Genetics (FLGT) Q4 2023 Earnings Call Transcript